Novel Technologies News for September 2013

Novel Technologies News Archive

Shark antibodies could provide key to targeting breast cancer Shark antibodies could provide key to targeting breast cancer

Aberdeen scientists are investigating if antibodies found naturally in sharks could be used to target breast cancer.

How meningitis bacteria ‘slip under the radar’ How meningitis bacteria ‘slip under the radar’

Scientists have discovered a natural temperature sensor in one of the bacteria that cause meningitis and blood poisoning, which allows them to evade the body’s immune response leading to life-threatening infections.

Cellectricon announces Cellaxess® ACE project grant winners Cellectricon announces Cellaxess® ACE project grant winners

Cellectricon, a leading provider of advanced cell-based screening technologies and services, has announced the two winners of its Cellaxess® ACE project grant, supporting cutting-edge research in cell biology.

Global Response to Pharma EXPO Grows with Support from Pharmintech Global Response to Pharma EXPO Grows with Support from Pharmintech

Initial space reservations place the new event well ahead of expectations.Industry support is growing for Pharma EXPO, the new pharmaceutical industry event from PMMI, The Association for Packaging and Processing Technologies, and the International Society for Pharmaceutical Engineering (ISPE). PMMI, the owner and producer of the PACK EXPO family of trade shows, announces a new partnership with Ipack-Ima Spa, which produces Pharmintech.

Royal Society of Chemistry Unveils its Conference for Lab Innovations 2013 Royal Society of Chemistry Unveils its Conference for Lab Innovations 2013

The Royal Society of Chemistry (RSC) is bringing together leading scientists, technical experts and two of science’s most famous names, in a special free-to-attend conference at easyFairs LAB INNOVATIONS on 6 &7 November 2013 at Birmingham’s NEC.

Muscular Dystrophy Genetic Therapy Might Have Died Without Patient Group Support Muscular Dystrophy Genetic Therapy Might Have Died Without Patient Group Support

A type of gene therapy heralded as a potentially revolutionary treatment for a severe form of muscular dystrophy was treated with scepticism by major medical funding establishments, and was mostly funded through its earliest development by patient groups.

MED-EL Founder and CEO Dr. Ingeborg Hochmair to Receive Prestigious Lasker Award for Development of the Modern Cochlear Implant MED-EL Founder and CEO Dr. Ingeborg Hochmair to Receive Prestigious Lasker Award for Development of the Modern Cochlear Implant

Worldwide hearing implant leader MED-EL Medical Electronics today announced that its Founder and CEO Ingeborg Hochmair, PhD, has been selected to receive this year's prestigious Lasker-DeBakey Clinical Medical Research Award for the development of the modern cochlear implant, a device that restores hearing to individuals with severe-to-profound deafness through electrical stimulation of the auditory nerve. She will share the award with Graeme M. Clark (Emeritus, Univ. of Melbourne, Australia) and Blake S. Wilson (Duke University, NC, USA). This highly-respected scientific award honors scientists whose contributions have improved the clinical treatment of patients. The award ceremony will take place in New York City on Friday, September 20, 2013

University of Warwick wins Domainex’s first Discovery STAR Award to Support hunt for new Chagas Disease Treatment University of Warwick wins Domainex’s first Discovery STAR Award to Support hunt for new Chagas Disease Treatment

Domainex Ltd., a drug discovery company specialising in translational research support, has announced that the recipient of its first Discovery STAR Award; Professor Vilmos Fulop of the University of Warwick. This award will give Professor Fulop access to Domainex’s outstanding drug discovery capabilities to support his research for a much-needed new treatment for Chagas disease- a potentially life-threatening disease.

The latest issue of Drug Discovery Today is packed full of industry focused research articles, new developments in drug discovery, and expert comment and opinion. The latest issue of Drug Discovery Today is packed full of industry focused research articles, new developments in drug discovery, and expert comment and opinion.

The latest issue of Drug Discovery Today is packed full of industry focused research articles, new developments in drug discovery, and expert comment and opinion.

Zealand announces peptide drug research and development collaboration agreement with Lilly Zealand announces peptide drug research and development collaboration agreement with Lilly

Zealand Pharma has announced an exclusive peptide drug research and development collaboration agreement with Eli Lilly and Company (“Lilly”).

Scientists succeed in growing human brain tissue in "Test Tubes" Scientists succeed in growing human brain tissue in "Test Tubes"

Complex human brain tissue has been successfully developed in a three-dimensional culture system established in an Austrian laboratory.